Previous Page  13 / 22 Next Page
Information
Show Menu
Previous Page 13 / 22 Next Page
Page Background

Volume 2, Issue 2 (Suppl)

Chronic Obstructive Pulmonary Diseases

ISSN: 2572-5548

Page 60

conferenceseries

.com

CO-ORGANIZED EVENT

August 31-September 01, 2017 Brussels, Belgium

&

International Conference on

Chronic Diseases

6

th

International Conference on

Microbial Physiology and Genomics

Probiotics as an adjunct treatment in the eradication of

Helicobacter pylori

infection: A meta-analysis

study

Higinio T Mappala

and

Jeffri Louie Ulip

Jose R Reyes Memorial Medical Center, Philippines

Introduction:

Helicobacter pylori

(HP) infection accounts for majority of cases of dyspeptic conditions with a prevalence

rate of approximately 51.7% in the Philippines as of 2013. Mainstay of treatment has been the standard combined therapy

consisting of a Proton Pump Inhibitor (PPIs) plus clarithromycin and metronidazole or amoxicillin. Probiotics, are live micro-

organisms, which when administered in adequate amounts, modulate the gut microbiome in the host. There are several studies

which show that the addition of probiotics to the treatment regimen of HP infection could lead to higher eradication rate.

Aim:

This is a meta-analysis study intends to determine the effect of the addition of probiotics compared to the conventional

treatment of HP infection.

Methodology:

Electronic databases used were PubMed, Cochrane Library, and Google Scholar and other targeted web

searches. The search was limited to human studies only from the years 2002-2013, 10 studies were included. This review

included patients who were randomly screened to have

H. pylori

infection, regardless of gender, with no age restriction. The

interventions used were a combination treatment of triple therapy with probiotics and treatment of triple therapy alone as the

control group. Outcome was measured by determining HP eradication rates between the two groups. Data will be analyzed

using RevMan 5.

Results:

In this meta-analysis with a combined total of 1,038 patients, 54% of patients were assigned to the triple therapy plus

probiotic group and 46% under the standard triple therapy alone. Results showed an increased eradication rate of HP from 71%

in the triple therapy alone group compared to 82% in the triple therapy group plus probiotics (P value-0.00001).

Conclusion:

This meta-analysis of 10 RCTs involving 1,038 patients showed that the addition or supplementation of a probiotic

to the standard treatment regimen for

Helicobacter pylori

infection significantly improved eradication rates (P value-0.00001).

genemapmd@yahoo.com

Chron Obstruct Pulmon Dis 2017, 2:2

DOI: 10.21767/2572-5548-C1-003